Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3983.00 | 3839.00 | 1.0375 | 1.0729 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 1582.00 | 3839.00 | 0.4121 | -0.1550 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 2500.00 | 1881.33 | 2835.00 | 3839.00 | 0.7385 | 0.4896 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 2500.00 | 1881.33 | 1896.00 | 3839.00 | 0.4939 | 0.0076 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3952.00 | 3839.00 | 1.0294 | 1.0572 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 3800.00 | 3839.00 | 0.9898 | 0.9803 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 2118.00 | 3839.00 | 0.5517 | 0.1221 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 2500.00 | 1881.33 | 2009.00 | 3839.00 | 0.5233 | 0.0659 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 2194.00 | 3839.00 | 0.5715 | 0.1612 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3472.00 | 3839.00 | 0.9044 | 0.8139 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 2500.00 | 1881.33 | 1953.00 | 3839.00 | 0.5087 | 0.0370 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3623.00 | 3839.00 | 0.9437 | 0.8906 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 1.00 | 3839.00 | 0.0003 | -0.9993 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 3.00 | 5706.50 | 0.0005 | -0.9734 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5695.00 | 5706.50 | 0.9980 | 0.9977 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5538.00 | 5706.50 | 0.9705 | 0.9660 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 5346.00 | 5706.50 | 0.9368 | 0.9267 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5413.00 | 5706.50 | 0.9486 | 0.9405 | |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 5000.00 | 1699.69 | 3362.00 | 5706.50 | 0.5892 | 0.4775 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 5000.00 | 1699.69 | 4618.00 | 5706.50 | 0.8093 | 0.7719 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 5000.00 | 1699.69 | 3270.00 | 5706.50 | 0.5730 | 0.4542 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5192.00 | 5706.50 | 0.9098 | 0.8947 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 3785.00 | 5706.50 | 0.6633 | 0.5812 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 4255.00 | 5706.50 | 0.7456 | 0.6908 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 5224.00 | 5706.50 | 0.9155 | 0.9014 |